Normal stool is usually brown due to bile produced in the liver
However, it is crucial to understand that BPC-157 is not approved for human use by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, the European Medicines Agency (EMA), or the US Food and Drug Administration (FDA)
But in terms of actual numbers of how many women benefitted, its smaller than a 1 percentage point absolute risk reduction
All anti obesity medications including semaglutide, tirzepatide, and liraglutide, may carry gastrointestinal adverse events such as abdominal pain, decreased appetite, and nausea, and they should be used under close medical supervision, particularly in individuals with a family medical history of thyroid cancer, or existing cardiovascular disease, chronic kidney disease, or risk of heart attack
This approach keeps your medical weight loss program structured, safe, and aligned with your long-term health goals
Realistic timeline: Weeks 1-4: Appetite changes happen relatively quickly